Vendor, Dallas, TX
HKS Inc.
UEI EU9MKWVA1TF8, CAGE 0WRP0
1 award and $1,254,904 obligated between April 5, 2024 and July 2, 2024, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $1,254,904 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40124C00047Definitive Contract, April 5, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Developing a Prototype Virtual Reality Experience of Home Environments That Foster Health and Wellness for Those Living with Diabetes: a SteNAICS 541714, PSC B504 | $1,254,904 |
- Places of performance
- Texas
- Product and service codes
- B504 Chemical/Biological Studies and Analysis
- Transactions
- 2 across 1 awards